Cited by — FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non–small cell lung cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non–small cell lung cancer.
No admitted local citation edges point to this work yet.
